South San Francisco, Calif. (BUSINESS WIRE) - Fluidigm Corporation today announced that Hazelle Lam has joined the company as one of its Regional Sales Directors for Asia. Ms. Lam will serve customers in Singapore, Hong Kong, Southeast Asia, China and Australia. Fluidigm develops, manufactures and markets integrated fluidic circuits (IFCs) for the life sciences market.
"Fluidigm's integrated fluidic circuit technology significantly improves productivity in life science research.
Our IFC architectures are highly flexible, and can be designed to support a wide range of applications and assay types," explained Ms. Lam. "I look forward to serving our customers throughout Asia."
Ms. Lam, based in Singapore, has substantial experience in sales, marketing and management in the life sciences market place and across the Asia Pacific region. She holds diplomas in Biotechnology and International Business from Ngee Ann Polytechnic in Singapore.
About Fluidigm
Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology" are made possible by miniaturizing and integrating liquid handling components on a single microfabricated device. Fluidigm's IFC systems, consisting of instrumentation, software and single-use IFCs, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the Food and Drug Administration for use as a diagnostic and are only available for research use.
For more information, please visit www.Fluidigm.com.
Fluidigm, the Fluidigm logo, Topaz, BioMark, and NanoFlex are trademarks of Fluidigm Corporation.
Fluidigm Corp.
Howard High, 650-266-6081 (office)mobile: 510-786-7378
"Fluidigm's integrated fluidic circuit technology significantly improves productivity in life science research.
Our IFC architectures are highly flexible, and can be designed to support a wide range of applications and assay types," explained Ms. Lam. "I look forward to serving our customers throughout Asia."
Ms. Lam, based in Singapore, has substantial experience in sales, marketing and management in the life sciences market place and across the Asia Pacific region. She holds diplomas in Biotechnology and International Business from Ngee Ann Polytechnic in Singapore.
About Fluidigm
Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology" are made possible by miniaturizing and integrating liquid handling components on a single microfabricated device. Fluidigm's IFC systems, consisting of instrumentation, software and single-use IFCs, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the Food and Drug Administration for use as a diagnostic and are only available for research use.
For more information, please visit www.Fluidigm.com.
Fluidigm, the Fluidigm logo, Topaz, BioMark, and NanoFlex are trademarks of Fluidigm Corporation.
Fluidigm Corp.
Howard High, 650-266-6081 (office)mobile: 510-786-7378
No comments:
Post a Comment